COSMOS Pharmaceutical Corporation (TYO: 3349)

COSMOS Pharmaceutical Revenue

COSMOS Pharmaceutical had revenue of 261.84B JPY in the quarter ending August 31, 2024, with 8.35% growth. This brings the company's revenue in the last twelve months to 985.18B, up 14.13% year-over-year. In the fiscal year ending May 31, 2024, COSMOS Pharmaceutical had annual revenue of 964.99B with 16.59% growth.

• Revenue (ttm): 985.18B
• Revenue Growth: +14.13%
• P/S Ratio: 0.57
• Revenue / Employee: 178.73M
• Employees: 5,512
• Market Cap: 558.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2024	964.99B	137.29B	16.59%
May 31, 2023	827.70B	72.28B	9.57%
May 31, 2022	755.41B	28.99B	3.99%
May 31, 2021	726.42B	42.02B	6.14%
May 31, 2020	684.40B	73.27B	11.99%